Glycomimetics Inc (GLYC) USD0.001
Sell:$0.22Buy:$0.22
$0.01
(4.63%)
- This stock can be held in a
Stocks and Shares ISA$0.01
(4.63%)$0.01
(4.63%)Company Information
About this company
GlycoMimetics, Inc. is a biotechnology company. The Company has no ongoing operations, is not performing any research and development, and is preserving cash until the contemplated merger and private placement. The Company was developing a pipeline of proprietary glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in important biological processes, to inhibit disease-related functions of carbohydrates such as the roles they play in cancers and inflammation.
Key people
Key facts
- EPICGLYC
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS38000Q1022
- Market cap$14.76m
- Employees4
- Shares in issue64.53m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.